Anti-Aging Stack

Anti‑Aging Stack – BPC‑157 · TB‑500 · KPV · Retatrutide · MOTS‑C · Epitalon · SS‑31

The Anti‑Aging Stack is designed for advanced researchers who want to study “healthy aging” as an emergent systems process, not a single target. By pairing regenerative and anti‑inflammatory peptides (BPC‑157, TB‑500, KPV) with a triple‑incretin metabolic agent (Retatrutide), a mitochondrial‑derived peptide (MOTS‑C), a pineal bioregulator (Epitalon), and a mitochondria‑targeted antioxidant (SS‑31), this stack allows you to interrogate structural integrity, metabolic efficiency, mitochondrial resilience, and genomic/circadian signals within one cohesive protocol.

Key components and conceptual roles

• BPC‑157 – Structural and organ‑protection axis
  A gastric‑derived pentadecapeptide widely used in research on tendon, ligament, muscle, gut, vascular, and neural repair. In an anti‑aging context, it anchors the tissue‑protection and microvascular arm of the stack, especially under chronic mechanical or metabolic stress.

• TB‑500 – Cell migration and connective‑tissue repair
  A thymosin‑beta‑4–inspired peptide associated with actin remodeling, cell migration, and angiogenesis. It complements BPC‑157 as a soft‑tissue and joint‑recovery agent, relevant to mobility, flexibility, and post‑injury models.

• KPV – Anti‑inflammatory and barrier support
  A short α‑MSH‑derived tripeptide used to study NF‑κB/MAPK‑linked inflammation, epithelial barrier function, and immune balance. It adds a targeted inflammation‑modulation layer, important where chronic low‑grade inflammation is a hallmark of aging models.

• Retatrutide – Metabolic and body‑composition axis
  A triple incretin agonist candidate (GIP/GLP‑1/glucagon receptors) used in obesity and diabetes research. Here, it supports the energy‑balance and adiposity component of the stack, allowing investigation of how improved metabolic profiles impact downstream aging‑relevant endpoints.

• MOTS‑C – Mitochondrial‑derived metabolic signal
  A mitochondrial peptide studied for AMPK activation, improved insulin sensitivity, exercise‑like adaptations, and stress‑response reprogramming. It contributes a mitochondrial and metabolic resilience signal, linking mitochondrial status to nuclear gene expression and systemic metabolism.

• Epitalon – Telomere and circadian‑rhythm bioregulator
  A pineal tetrapeptide associated in research with telomerase activation, telomere maintenance, melatonin/circadian modulation, and aging‑related gene‑expression changes. It forms the genomic and circadian‑aging layer of the stack.

• SS‑31 – Mitochondria‑targeted antioxidant
  A small tetrapeptide that localizes to the inner mitochondrial membrane and is investigated for stabilizing cardiolipin, reducing mitochondrial ROS, and supporting ATP production. It is the direct mitochondrial‑protection component, particularly relevant to heart, skeletal muscle, brain, kidney, and retina models.

Together, these agents let investigators explore how improving tissue repair, reducing chronic inflammation, optimizing metabolism and body composition, and directly supporting mitochondrial and genomic stability might interact in anti‑aging and “healthspan” research.

Research applications

This Anti‑Aging Stack can be deployed in experimental systems focused on:

• Musculoskeletal aging and mobility
  Tracking strength, endurance, joint function, connective‑tissue quality, and recovery after repeated mechanical stress or injury.

• Metabolic aging and body‑composition drift
  Studying shifts in visceral vs subcutaneous fat, lean‑mass retention, resting energy expenditure, and insulin sensitivity across the lifespan or in accelerated‑aging models.

• Mitochondrial function and redox balance
  Evaluating mitochondrial respiration, membrane potential, mitochondrial ROS, and bioenergetic capacity in cardiac, skeletal muscle, neural, and renal tissues.

• Cellular aging, telomere biology, and circadian disruption
  Connecting telomere and telomerase metrics, circadian markers, inflammatory and senescence markers, and functional outcomes (cognition, performance, recovery).

Handling and storage

• For controlled laboratory research use only, by trained professionals.

• Store all vials in a cool, dry environment away from light; follow your institution’s SOPs for peptide/small‑molecule storage, reconstitution, aliquoting, labeling, and disposal.

• Protocol design (doses, frequency, timing vs feeding/sleep, and duration) should be based on the primary question—e.g., musculoskeletal aging vs cardio‑metabolic vs neurocognitive—and the established literature for each component.

Important disclaimer

All compounds sold by Rocky Peptide Chain, including the Anti‑Aging Stack (BPC‑157, TB‑500, KPV, Retatrutide, MOTS‑C, Epitalon, and SS‑31), are for research use only. They are not intended for human consumption, medical use, cosmetic use, diagnostic purposes, or treatment of any disease or condition. No claims are made or implied regarding anti‑aging, life extension, disease prevention, performance enhancement, or any therapeutic or cosmetic benefit. Researchers are solely responsible for appropriate handling, experimental design, and compliance with all applicable regulations.